awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35010979-5538295E-DCB5-4597-9F0F-DF3585FCDBF2
Q35010979-5538295E-DCB5-4597-9F0F-DF3585FCDBF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35010979-5538295E-DCB5-4597-9F0F-DF3585FCDBF2
Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.
P2860
Q35010979-5538295E-DCB5-4597-9F0F-DF3585FCDBF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35010979-5538295E-DCB5-4597-9F0F-DF3585FCDBF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
45d8353b7735d9068478414b5828556cdcb0897f
P2860
Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.